Engineering on Algae and Cyanobacteria for Production of Pharmaceutical and Functional Ingredients

Dear Colleagues,

Algae (microalgae and macroalgae/seaweed) and cyanobacteria are recognized as a source of a broad spectrum of chemicals, including omega 3/6 fatty acids, triacylglycerol and bioactive molecules. Microalgae have gained renewed interest as biofuel in recent years, leading to significant advancement in the development of cultivation and harvesting systems, as well as cultivation strategies. Algae and cyanobacteria are also recognized as a source of bioactive molecules. These organisms are the source of structurally diverse and complex bioactive molecules, which may be difficult to produce through chemical synthesis. Thus, we would like to bring to your attention that the Journal of Marine Drugs (IF: 4.07) is devoting a Special Issue (SI) to the topic of algae and cyanobacteria beyond biofuel, focused on the production of algae and cyanobacteria for pharmaceutical and functional food applications, as well as recovery of bioactive molecules from these organisms.

You are welcomed to contribute original research/critical review manuscripts in the following themes. All manuscripts will go through a peer review process. It is our goal to bring the highest quality SI on the topic of algae and cyanobacteria for pharmaceuticals and functional food to our audience.

• Metabolic engineering of algae and cyanobacteria for pharmaceutical and functional food production
• Process development for derivation of bioactive molecules from algae and cyanobacteria
• Innovative cultivation systems for autotrophic, heterotrophic and mixotrophic cultivation of algae and cyanobacteria beyond biofuel application
• Development of cultivation strategies for production of algae and cyanobacteria beyond biofuel application

Dr. Azadeh Kermanshahi-Pour
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• microalgae
• macroalgae
• seaweed
• pharmaceutical
• functional food
• bioactive compounds
• metabolic engineering
• algae cultivation
• cultivation conditions